Operating out of South Africa during the Apartheid era in the early 1980’s, Dr. Wouter Basson launched a secret bioweapons project called Project Coast. The goal of the project was to develop biological and chemical agents that would either kill or sterilize the black population and assassinate political enemies. Among the agents developed were Marburg and Ebola viruses.
Basson is surrounded by cloak and dagger intrigue, as he told Pretoria High court in South Africa that “The local CIA agent in Pretoria threatened me with death on the sidewalk of the American Embassy in Schoeman Street.” According to a 2001 article in The New Yorker magazine, the American Embassy in Pretoria was “terribly concerned” that Basson would reveal deep connections between Project Coast and the United States.
In 2013, Basson was found guilty of “unprofessional conduct” by the South African health council.
Bioweapons expert Jeanne Guillemin writes in her book Biological Weapons: From the Invention of State-Sponsored Programs to Contemporary Bioterrorism, “The project‘s growth years were from 1982 to 1987, when it developed a range of biological agents (such as those for anthrax, cholera, and the Marburg and Ebola viruses and for botulinum toxin)…“
Basson’s bioweapons program officially ended in 1994, but there has been no independent verification that the pathogens created were ever destroyed. The order to destroy them went directly to Dr. Basson. According to the Wall Street Journal, “The integrity of the process rested solely on Dr. Basson’s honesty.”
Basson claims to have had contact with western agencies that provided “ideological assistance” to Project Coast. Basson stated in an interview shot for the documentary Anthrax War that he met several times with Dr. David Kelly, the infamous UN weapons inspector in Iraq. Kelly was a top bioweapons expert in the United Kingdom. He was found dead near his home in Oxfordshire in 2003. While the official story claims he committed suicide, medical experts highly doubt this story.
In a 2007 article from the Mail Online, it was reported that a week prior to his death, Dr. Kelly was to be interviewed by MI5 about his ties to Dr. Basson.
Dr. Timothy Stamps, Minister of Health of Zimbabwe, suspected that his country was under biological attack during the time that Basson was operating. Stampstold PBS Frontline in 1998 that “The evidence is very clear that these were not natural events. Whether they were caused by some direct or deliberate inoculation or not, is the question we have to answer.”
Stamps specifically named the Ebola and Marburg viruses as suspect. Stamps thinks that his country was being used as a testing ground for weaponized Ebola.
“I’m talking about anthrax and cholera in particular, but also a couple of viruses that are not endemic to Zimbabwe [such as] the Ebola type virus and, we think also, the Marburg virus. We wonder whether in fact these are not associated with biological warfare against this country during the hostilities… Ebola was along the line of the Zambezi [River], and I suspect that this may have been an experiment to see if a new virus could be used to directly infect people.”
The Ghanaian Times reported in early September on the recent Ebola outbreak, noting connections between Basson and bioweapons research. The article points out that, “…there are two types of scientists in the world: those who are so concerned about the pain and death caused to humans by illness that they will even sacrifice their own lives to try and cure deadly diseases, and those who will use their scientific skill to kill humans on the orders of… government…”
Indeed, these ideas are not new. Plato wrote over 2,000 years ago in his work The Republic that a ruling elite should guide society, “…whose aim will be to preserve the average of population.” He further stated, “There are many other things which they will have to consider, such as the effects of wars and diseases and any similar agencies, in order as far as this is possible to prevent the State from becoming either too large or too small.”
As revealed by The Age, Nobel prize winning Australian microbiologist Sir Macfarlane Burnet secretly urged the Australian government in 1947 to develop bio weapons for use against the “overpopulated countries of South-East Asia.” In a 1947 meeting with the New Weapons and Equipment Development Committee, the group recommended that “the possibilities of an attack on the food supplies of S-E Asia and Indonesia using B.W. agents should be considered by a small study group.”
This information gives us an interesting perspective on the recent unprecedented Ebola outbreak. Is it an organic natural phenomenon? Did this strain of Ebola accidentally escape from a bioweapons lab? Or, was it deliberately released?
Ebola with the U.S. Army at Ft. Detrick Maryland but that the research was inexplicably shut down two weeks before the first outbreak of the virus in West Africa.
Richard C. Davis, M.D., a former flight surgeon with the U.S. Navy, told Infowars that he was leading a project to develop a drug called RC-2Beta, which according to Davis works, “at the core of our cells to enhance mitochondrial efficiency and promote gene signaling to stimulate cellular self-repair and pathogen destruction.”
In the fall of 2013, Davis’ company began collaborating with the US Army at their Level 4 bioweapons facility at Ft. Detrick, Maryland to develop the drug, with astounding success.
According to Davis, the drug “Killed four of the world’s deadliest viruses in a dose-dependent fashion. The Army also noted that uninfected cells in the same cultures were untouched by the drug (i.e., it was non-toxic).”
“Everyone was very excited about these results since there has never been a broad-spectrum anti-viral drug that killed so many different viruses without affecting normal (uninfected) cells in this way,” writes Davis.
However, after the Army initially indicated to Davis and his team that they were ready to move ahead quickly with further testing, communication completely ceased.
Army research data shows effectiveness of RC-2Beta in fighting the Ebola virus.
“Our once close communications and cordial relationship with the Ft. Detrick team went totally and inexplicably silent. Our phone calls went unanswered and emails unreturned,” writes Davis, adding he was “stunned” when the first reports of Ebola emerged in Africa just two weeks later.
The doctor also desperately contacted mainstream media outlets in an effort to get the story out, including CNN, ABC, MSNBC, CBS, the New York Times, the Washington Post, the LA Times and others. After making initial contact and agreeing to provide documents, Davis was subsequently stonewalled and every outlet dropped the story.
Davis then turned to Florida Congressman David Jolly in an effort to reopen lines of communication with Ft. Detrick, a process that is ongoing.
While health authorities and the media aggressively promoted ZMapp and other less successful drugs and vaccines to fight Ebola, Davis set about anxiously contacting the World Health Organization, which in June announced that experimental treatments for Ebola would be fast tracked.
“Out of concern and frustration, I made it my personal priority to obtain the two necessary documents (Humanitarian Use Exemption and Export Certificate) needed to ship our drug to the medical teams working desperately in Africa,” writes Davis. “So I began calling, and writing and faxing everyone who might be able to help. Since May, I have reached out over 200 times to every head of every organization in the world involved with this crisis. This includes the World Health Organization, the Centers for Disease Control, the various teams at the FDA, the National Institutes of Health, DARPA, multiple private relief and aid organizations (like Doctors Without Borders), and dozens just like them. The response was always the same… Silence…”
The doctor also slammed the Obama administration’s response to the Ebola outbreak.
“The response of the American government has been patently absurd,” writes Davis. “Every protocol that has been put in place to prevent the spread of the disease has been ignored. Our borders remain open, infected patients are being brought into our hospitals, and no truly effective countermeasures have been erected to stem the tide of infectious risk.”
Davis’ conclusion on the government’s handling of the Ebola crisis and the fact that a potentially successful cure for the virus was shut down by Ft. Detrick immediately before the outbreak in West Africa left him to draw a sobering conclusion.
“I am left to conclude that America’s leadership is either guilty of gross misconduct, dereliction of duty, criminal negligence or worse – treason,” writes Davis, warning that the “crisis will undoubtedly spiral out of control” if the advice of incompetent public health authorities, the government and the media continues to be followed unquestionably.
Davis boasts an impressive Curriculum Vitae, having authored over 400 patents and trademarks while also being awarded commendations from the Chief of Naval Operations.
“The inescapable conclusions of negligence or corruption or both cannot be simply swept aside for the sake of political correctness when the lives of every one of us are at stake,” writes Davis, adding, “Ebola is real. It is here, now. There is no more time to waste.”
One key U.S. driven lie has to do with the Western MSM’s insistence that nobody of any repute believes that Ebola might be airborne. On this issue, the Public Health Agency of Canada remarks:
In the laboratory, infection through small-particle aerosols has been demonstrated in primates, and airborne spread among humans is strongly suspected, although it has not yet been conclusively demonstrated (1, 6, 13). The importance of this route of transmission is not clear. Poor hygienic conditions can aid the spread of the virus.
A few scientific studies expressing concern about the airborne possibility are cited in this article, and other such studies are not hard to find.
So there are people with authority to speak to the issue who believe that there is some cause for concern regarding the airborne Ebola prospect, but the U.S. government/MSM complex instead lies and acts like this isn’t the case.
Before getting to the second U.S. lie, it is important to mention three facts that have not received enough discussion. First—and this may be of pivotal significance–we still have no idea how Ebola got to West Africa. See for yourself; there’s never been an Ebola outbreak in West Africa before.
Perhaps the racist U.S./MSM view is that all African countries are the same, so who cares?
Second, the current outbreak, in terms of the number and international breadth of infections, does seem to be far more contagious than any previous outbreak; as the previous link shows, we now have at least 1,975 cases.
Now pause for a moment and take this fully on board: the 1,975 cases exceed the total number of Ebola cases from 1977 to 2014’s outbreak. So it’s no surprise that we have, for example, signs of infected individuals in Albania.
The second lie really is a lie of nondisclosure, and concerns the reality that the MSM has not told us that we are dealing with a biologically distinct form of Ebola that has never been seen before.
So, consider the following disconcerting information appearing in the New England Journal of Medicine in April 2014 regarding the current West African, Guinean outbreak of Ebola:
Phylogenetic analysis of the full-length sequences established a separate clade for the Guinean EBOV strain in sister relationship with other known EBOV strains. This suggests that the EBOV strain from Guinea has evolved in parallel with the strains from the Democratic Republic of Congo and Gabon from a recent ancestor and has not been introduced from the latter countries into Guinea. Potential reservoirs of EBOV, fruit bats of the species Hypsignathusmonstrosus, Epomopsfranqueti, & Myonycteristorquata, are present in large parts of West Africa.18 It is possible that EBOV has circulated undetected in this region for some time. The emergence of the virus in Guinea highlights the risk of EBOV outbreaks in the whole West African subregion.
Furthermore, from the same study:
The high degree of similarity among the 15 partial L gene sequences, along with the three full-length sequences and the epidemiologic links between the cases, suggest a single introduction of the virus into the human population. This introduction seems to have happened in early December 2013 or even before.
So, the Guinean variant of Ebola we now confront has been found to be sufficiently genetically distinct from all previous versions of Ebola that it has been assigned its own genetic branch, or clade, and it is believed to have evolved in parallel from an ancestor held in common with a variant of Ebola native to the Democratic Republic of Congo and Gabon. Moreover, the current outbreak began not in June or July, but as early as April 2014 and perhaps even earlier than December, 2013.
And, we seem to have a single introduction of the Guinea (West African) Ebola variant into the human population. Thus, we seem not to have, for example, something along the lines of multiple bites of humans by supposedly Guinea variant Ebola infected fruit bats.
Finally, the Western Africa Ebola outbreak does not appear to be traceable to Central Africa or anywhere else, and so we still do not know how Ebola got to West Africa.
Let us briefly summarize before presenting the third U.S. Ebola lie and concluding with a reasonable explanation that ties the three lies together.
The Guinea Ebola variant has never been seen before. It might well be far more contagious than any Ebola variant hitherto encountered; it could even be airborne. We still have no idea how Ebola arose in West Africa, but it did so some time ago—well before the Western MSM started to spew its lies.
Now the third U.S. Ebola lie: In a Matt Drudge-linked article entitled “The Federal Government’s Inconsistent Ebola Story”, we find that the U.S. government is telling two completely inconsistent stories regarding the circumstances surrounding delivery of MappPharmaceuticals’ magic ZMapp Ebola drug to Dr. Kent Brantly and Nancy Writebol. Thus, we have:
According to the CDC, it was Samaritan’s Purse, the private humanitarian organization that employs Dr. Brantley, who reached out to them in an attempt to find an experimental Ebola drug. The CDC says it passed Samaritan’s Purse along to NIH, who referred them to contacts within Mapp.
“This experimental treatment was arranged privately by Samaritan’s Purse,” the CDC said. “Samaritan’s Purse contacted the Centers for Disease Control and Prevention (CDC), who referred them to the National Institutes of Health (NIH). NIH was able to provide the organization with the appropriate contacts at the private company developing this treatment. The NIH was not involved with procuring, transporting, approving, or administering the experimental treatments.”
The New York Times first reported this version of events on Aug. 6, and the statement was posted on the CDC’s website a few days later,where it remains.
But the NIH told Morning Consult one of its scientists on the ground in West Africa approached the charity before the group had even decided to pursue an experimental alternative.
“The NIH scientist who was in West Africa referred Samaritan’s Purse to company contacts because they were best equipped to answer questions about the status of their experimental treatment,” the agency said in an email to Morning Consult. “This occurred before Samaritan’s Purse decided to pursue an experimental therapy.”
A statement from Samaritan’s Purse also conflicts with the CDC’s telling of events, and indicates the NIH and other government agencies may have played an active role in procuring the drugs.
“The experimental medication given to Dr. Brantley was recommended to us,” the group said. “We didn’t seek it out, but worked with the National Institutes of Health and other government agencies to obtain this medication.”
Hence, we have the U.S. government saying both that delivery of the drug to the aid workers was initially government’s idea, and that it wasn’t initially government’s idea. Since both of these possibilities cannot be true, we have our third U.S. federal Ebola lie.
But whose idea was it, really, to deliver the ZMapp magic serum (which is said to have begun reversing Brantly’s condition within 20 minutes to an hour)? In all likelihood it was the U.S. government’s idea, at a minimum for the following reason mentioned in the Morning Consult article:
If [Mapp] did this on their own, they must have had unbelievable confidence in the product and lawyers who know this up and down,” Vox said. “If they went this alone, their investors should be worried, because that’s reckless. A team of scientists could get in a lot of trouble doing that, and I can’t imagine they run their company that way, especially considering they have support from the Department of Defense.
Let’s put all of the above together and move toward wrapping matters up.We have what appears to be the most contagious variant of Ebola ever encountered, its genetic form is novel in important respects, and we still have no idea how it arose in West Africa.
Yet, we are told that an experimental drug, ZMapp—produced by a previously unheard of U.S. firm with U.S. Department of Defense ties—is functioning in miraculous fashion. Furthermore, the U.S. government cannot keep its story straight about who initiated the delivery of the experimental drug to the U.S. aid workers, but there are compelling reasons to suppose it was the U.S. government that engineered the delivery.
All of the foregoing should prompt us to ask: When was Mapp Pharmaceutical’s magic drug ZMappdeveloped?
The following language, drawn from an article at International Business Times, might provide guidance:
A statement from Mapp said:
“ZMapp is the result of a collaboration between Mapp Biopharmaceutical Inc, LeafBio, DefyrusInc, the US government and Public Health Agency of Canada.
“ZMapp is composed of three ‘humanized’ monoclonal antibodies manufactured in plants, specifically Nicotiana. It is an optimized cocktail combining the best components of MB-003 and ZMAb.
“ZMapp was first identified as a drug candidate in January 2014 and has not yet been evaluated for safety in humans. As such, very little of the drug is currently available. Any decision to use an experimental drug in a patient would be a decision made by the treating physician under the regulatory guidelines of the FDA.
One very interesting thing to note is the parties involved in producing ZMapp. Two of the parties are the U.S. government and the Public Health Agency of Canada—and the Public Health Agency of Canada, you will recall, is the very same agency that “strongly suspects” that Ebola might be airborne (see the second paragraph of this article). Yet, we are constantly told the U.S. government suspects no such thing.
But there are even more important things to consider.
Does “ZMapp was first identified as a drug candidate in January 2014” mean that ZMappwas designed from the ground up, pretty much when the outbreak began, with the specific purpose of treating the Guinea Ebola variant (see above for timing of the outbreak)? Or, does it mean that ZMapp was repurposed in some way to grapple with the Guinea variant? Or does it perhaps mean something else entirely?
In any event, if the above MappPharmaceuticals statement is true, this much is perfectly clear: a major decision about ZMapp and its potential efficacy was made in January 2014, and that decision appears to have been made very close on the heels of the beginning of the current Guinea Ebola outbreak.
Therefore, if ZMapp really is the miraculous success it is purported to be, we are given to believe that, in Research and Development terms, results must have been achieved virtually overnight. This is because with the beginning of the outbreak of the brand newGuinea Ebola variant dated to around December 2013, Mapp could not possibly have had much time before its January 2014 decision to target the Guinea Ebola variant with ZMapp.
Or might Mappin fact have had plenty of time?
One possibility is that Mappdid have plenty of time, because it knew about the brand new Ebola variant before its debut appearance in West Africa. This would be very strong evidence of a bioterror conspiracy, would it not? Of course, we are very far from sure about this prospect.
However, even if we are to believe that Mapp did not know about the novel Guinea Ebola variant before that variant’s first appearance, but did in fact advance anyway with ZMapp againstthe Guinea variant in January 2014, we must still ask exactly how ZM appended up being effective against a brand new variant Mapp would, under the present assumption, have only just encountered.
Perhaps Mapp had been in the process of designing ZMapp so that it could successfully attack already extant Ebola variants, and whatever properties made it effective against those already extant variants also transferred to the novel Guinea variant?
But if that is so, ZMapp should prove successful against variants of Ebola other than the Guinea variant. Will it?
If it doesn’t prove successful against variants of Ebola other than the Guinea variant, I do not see how one can logically avoid the conclusion that the West African rooted, Guinea variant of Ebola amounts to U.S. government linked bioterror.
Unless, of course, one is willing to invoke what amounts to a miraculous stroke of luck consisting in the design of a solution that successfully attacks something that’s never been seen before and was not anticipated—even though the solution fails against related versions of the same problem.
In closing, please note that the U.S. act of bioterror explanation economically accounts for all three U.S. lies discussed in the article. It explains why the U.S. government is lying about the airborne status of Ebola, why the U.S. government/MSM hybrid is in no hurry to disclose the geographical and virological novelties of the Guinea variant, and, finally, why the U.S. government, out of one side of its mouth, wants to act like its “miracle experimental drug” had to be pried out of its greedy and comprehensive regulatory hands.
It must be stated, though, that there is one last possibility after all, which is that the Dr. Kent Brantly miracle recovery is no real recovery at all.